Bayer AG Company Profile (NASDAQ:BAYRY)

About Bayer AG (NASDAQ:BAYRY)

Bayer AG logoBayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BAYRY
  • CUSIP: N/A
  • Web: https://www.bayer.de/
Capitalization:
  • Market Cap: $115.64 billion
  • Outstanding Shares: 872,107,000
Average Prices:
  • 50 Day Moving Avg: $128.32
  • 200 Day Moving Avg: $125.53
  • 52 Week Range: $91.53 - $139.04
P/E:
  • Trailing P/E Ratio: 19.17
  • Foreward P/E Ratio: 13.54
  • P/E Growth: 2.47
Sales & Book Value:
  • Annual Revenue: $58.04 billion
  • Price / Sales: 1.99
  • Book Value: $44.79 per share
  • Price / Book: 2.96
Dividend:
  • Dividend Yield: 2.2%
Profitability:
  • EBIDTA: $13.85 billion
  • Net Margins: 10.90%
  • Return on Equity: 13.03%
  • Return on Assets: 6.36%
Misc:
  • Average Volume: 61,316 shs.
 

Frequently Asked Questions for Bayer AG (NASDAQ:BAYRY)

What is Bayer AG's stock symbol?

Bayer AG trades on the NASDAQ under the ticker symbol "BAYRY."

How often does Bayer AG pay dividends? What is the dividend yield for Bayer AG?

Bayer AG declared an annual dividend on Thursday, June 29th. Stockholders of record on Wednesday, May 3rd will be paid a dividend of $2.157 per share on Monday, May 15th. The ex-dividend date is Monday, May 1st. View Bayer AG's Dividend History.

How were Bayer AG's earnings last quarter?

Bayer AG (NASDAQ:BAYRY) posted its quarterly earnings results on Thursday, July, 27th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.87 by $0.12. The company earned $13.41 billion during the quarter, compared to the consensus estimate of $14.45 billion. Bayer AG had a return on equity of 13.03% and a net margin of 10.90%. View Bayer AG's Earnings History.

When will Bayer AG make its next earnings announcement?

Bayer AG is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Bayer AG.

Who are some of Bayer AG's key competitors?

Who are Bayer AG's key executives?

Bayer AG's management team includes the folowing people:

  • Werner Wenning, Chairman of the Supervisory Board
  • Werner Baumann, Chairman of the Management Board, Chief Executive Officer
  • Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative
  • Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board
  • Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director
  • Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit
  • Kemal Malik, Member of the Management Board, Innovation and the Latin America Region
  • Erica Mann, Member of the Management Board, Head of the Consumer Health Division
  • Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division
  • Paul Achleitner, Member of the Supervisory Board

How do I buy Bayer AG stock?

Shares of Bayer AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer AG's stock price today?

One share of Bayer AG stock can currently be purchased for approximately $132.60.


MarketBeat Community Rating for Bayer AG (NASDAQ BAYRY)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  190 (Vote Underperform)
Total Votes:  345
MarketBeat's community ratings are surveys of what our community members think about Bayer AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bayer AG (NASDAQ:BAYRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: N/A

Analysts' Ratings History for Bayer AG (NASDAQ:BAYRY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/3/2017Berenberg BankDowngradeBuy -> HoldLowView Rating Details
2/24/2017Sanford C. BernsteinReiterated RatingOutperformN/AView Rating Details
1/4/2017J P Morgan Chase & CoUpgradeNeutral -> OverweightN/AView Rating Details
12/19/2016Jefferies Group LLCUpgradeHold -> BuyN/AView Rating Details
9/14/2016Goldman Sachs Group, Inc. (The)Reiterated RatingBuyN/AView Rating Details
8/25/2016Citigroup Inc.UpgradeNeutral -> BuyN/AView Rating Details
5/25/2016Commerzbank AgUpgradeHold -> BuyN/AView Rating Details
5/25/2016Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
5/25/2016DZ Bank AGReiterated RatingBuyN/AView Rating Details
4/27/2016Credit Suisse GroupDowngradeOutperform -> NeutralN/AView Rating Details
4/8/2016Nord/LBReiterated RatingBuyN/AView Rating Details
3/7/2016Barclays PLCUpgradeUnderweight -> Equal WeightN/AView Rating Details
12/10/2015HSBC Holdings plcUpgradeHold -> BuyN/AView Rating Details
10/26/2015Societe GeneraleReiterated RatingNeutralN/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Bayer AG (NASDAQ:BAYRY)
Earnings by Quarter for Bayer AG (NASDAQ:BAYRY)
Earnings History by Quarter for Bayer AG (NASDAQ BAYRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$1.50N/AView Earnings Details
7/27/20176/30/2017$1.87$1.99$14.45 billion$13.41 billionViewN/AView Earnings Details
4/27/20173/31/2017$2.40$2.80$13.65 billion$14.11 billionViewN/AView Earnings Details
10/26/2016Q3$1.80$1.93$12.39 billion$12.57 billionViewListenView Earnings Details
10/29/2015Q3$1.65$1.88$12.79 billion$12.28 billionViewListenView Earnings Details
4/30/2015Q1 2015$2.35$2.33$12.81 billion$13.45 billionViewN/AView Earnings Details
2/26/2015Q4 2014$1.35$12.53 billionViewN/AView Earnings Details
7/30/2014Q2 2014$2.05$14.02 billionViewN/AView Earnings Details
4/24/2014Q1 2014$2.47$2.35$14.67 billion$14.59 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bayer AG (NASDAQ:BAYRY)
Current Year EPS Consensus Estimate: $8.99 EPS
Next Year EPS Consensus Estimate: $9.79 EPS

Dividends

Dividend History by Quarter for Bayer AG (NASDAQ BAYRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/29/2017Annual$2.165/1/20175/3/20175/15/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Bayer AG (NASDAQ:BAYRY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Bayer AG (NASDAQ:BAYRY)
Latest Headlines for Bayer AG (NASDAQ:BAYRY)
Source:
DateHeadline
nasdaq.com logoBayer: Business In Brazil To Return To Normal In 2018 - Quick Facts - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
nasdaq.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
nasdaq.com logoIs Bayer AG (BAYRY) a Great Stock for Value Investors? - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
americanbankingnews.com logoBayer AG (BAYRY) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - September 19 at 8:20 PM
finance.yahoo.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoBayer Shares Dip After Group Pushes Monsanto Closing Date into 'Early 2018'
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoBayer dismisses antitrust concerns about digital farming
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoIs Bayer AG (BAYRY) a Great Stock for Value Investors?
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges
finance.yahoo.com - September 19 at 4:21 PM
nasdaq.com logoMonsanto (MON) Upgraded to Buy on Robust Growth Drivers - Nasdaq
www.nasdaq.com - September 14 at 4:59 PM
nasdaq.com logoBASF Reportedly Bids For Bayer's Seed Assets - Nasdaq
www.nasdaq.com - September 14 at 4:59 PM
seekingalpha.com logoFDA OKs Bayer's lymphoma med Aliqopa - Seeking Alpha
seekingalpha.com - September 14 at 4:59 PM
finance.yahoo.com logoBASF's Late Grab for Bayer Seed Assets Marks Strategy Shift
finance.yahoo.com - September 14 at 4:59 PM
finance.yahoo.com logoBayer, Halvorsen's Viking Make Record Wager on Farming Tech
finance.yahoo.com - September 14 at 4:59 PM
nasdaq.com logoBayer Cuts Stake In Covestro, Places 9.4% Stake
www.nasdaq.com - September 13 at 2:38 AM
seekingalpha.com logoBayer submits European marketing application long-acting hemophilia A treatment
seekingalpha.com - September 7 at 4:24 PM
finance.yahoo.com logo[$$] Don’t Ignore Big Pharma’s New Breakthrough
finance.yahoo.com - September 6 at 4:15 PM
finance.yahoo.com logo[$$] Resilience Combines Three Medical-Device Businesses
finance.yahoo.com - September 6 at 4:15 PM
finance.yahoo.com logo[$$] Don't Ignore Big Pharma's New Breakthrough
finance.yahoo.com - September 5 at 5:56 PM
seekingalpha.com logoMonsanto: EU Launches In-Depth Probe Of Bayer Deal (Does It Matter?)
seekingalpha.com - September 4 at 3:54 PM
americanbankingnews.com logoBayer AG (BAYRY) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 2 at 2:44 AM
nasdaq.com logoPharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update - Nasdaq
www.nasdaq.com - September 1 at 8:34 PM
nasdaq.com logoJ&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III - Nasdaq
www.nasdaq.com - August 28 at 9:26 PM
finance.yahoo.com logoJ&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III
finance.yahoo.com - August 28 at 9:26 PM
americanbankingnews.com logoBayer AG (BAYRY) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 25 at 2:22 PM
finance.yahoo.com logoImmunomedics' Progress in Phase II Cancer Study Encouraging - Yahoo Finance
finance.yahoo.com - August 24 at 2:34 AM
nasdaq.com logoZoetis (ZTS) Poised to Grow on Companion Animal Portfolio - Nasdaq
www.nasdaq.com - August 22 at 5:06 PM
seekingalpha.com logoEU launches in-depth probe of Bayer-Monsanto deal - Seeking Alpha
seekingalpha.com - August 22 at 5:06 PM
nasdaq.com logoImmunomedics' Progress in Phase II Cancer Study Encouraging - Nasdaq
www.nasdaq.com - August 22 at 5:06 PM
seekingalpha.com logoJ&J, Bayer log third straight court win over Xarelto - Bayer A.G. ADR ... - Seeking Alpha
seekingalpha.com - August 19 at 2:31 AM
finance.yahoo.com logoBayer-Backed Health Startup Medopad Raises Funds With UBS
finance.yahoo.com - August 18 at 4:27 PM
nasdaq.com logoRegeneron's (REGN) RSV Drug Suptavumab Fails NURSERY Trial
www.nasdaq.com - August 16 at 10:12 PM
feeds.benzinga.com logoVistaGen Therapeutics Reports First Fiscal Quarter 2018 Financial Results and Provides Business Update
feeds.benzinga.com - August 14 at 4:49 PM
americanbankingnews.com logoBayer AG (NASDAQ:BAYRY) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - August 8 at 7:34 AM
nasdaq.com logoRegeneron (REGN) Beats on Q2 Earnings & Sales, Raises View - Nasdaq
www.nasdaq.com - August 3 at 10:53 PM
finance.yahoo.com logoBayer AG :BAYRY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017
finance.yahoo.com - August 2 at 5:09 PM
thestreet.com logoBayer Offers Concessions in $66 Billion Monsanto Deal to Ease Competition Concerns - TheStreet.com
www.thestreet.com - August 1 at 10:19 PM
seekingalpha.com logoMonsanto Sale To Bayer To Close In 2018 - Seeking Alpha
seekingalpha.com - July 31 at 4:30 PM
seekingalpha.com logoMonsanto Sale To Bayer To Close In 2018
seekingalpha.com - July 31 at 4:30 PM
finance.yahoo.com logoUPDATE 1-Bayer cuts profit forecast after consumer health headache
finance.yahoo.com - July 28 at 5:44 PM
americanbankingnews.com logoBayer AG (NASDAQ:BAYRY) Releases Earnings Results, Beats Expectations By $0.12 EPS
www.americanbankingnews.com - July 28 at 3:33 PM
finance.yahoo.com logoExpect deal with Monsanto to close by end of 2017, says B...
finance.yahoo.com - July 27 at 9:51 PM
finance.yahoo.com logoOur competitors do have similar issues: Bayer CEO
finance.yahoo.com - July 27 at 9:51 PM
finance.yahoo.com logoBayer CEO: Very important that we're up front with good &...
finance.yahoo.com - July 27 at 9:51 PM
nasdaq.com logoBayer Q2 Net Profit Declines, Net Sales Rise - Quick Facts
www.nasdaq.com - July 27 at 3:00 AM
nasdaq.com logoAVEO Pharmaceuticals (AVEO) Q2 Earnings: What's in Store? - Nasdaq
www.nasdaq.com - July 26 at 4:58 PM
finance.yahoo.com logoCan Regeneron Pharma (REGN) Pull a Surprise in Q2 Earnings?
finance.yahoo.com - July 26 at 4:58 PM
finance.yahoo.com logoReport: More than 15,000 Adverse Events Linked to Xarelto in 2016
finance.yahoo.com - July 25 at 4:19 PM
americanbankingnews.com logoBayer AG (BAYRY) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 24 at 1:36 PM
thestreet.com logoEuropean Stocks Set to Drift Lower Ahead of Active Week For Corporate Earnings - TheStreet.com
www.thestreet.com - July 24 at 12:37 PM

Social

Chart

Bayer AG (BAYRY) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff